A Study to Assess the Safety, Tolerability and Efficacy of ION775 | MicrobiomeTrials← Back to trialsNCT07604974
A Study to Assess the Safety, Tolerability and Efficacy of ION775
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05Est. Completion: 2027-09
Enrollment target: 72 participants Locations- Ionis Investigative Site, Lincoln, California, United States
- Ionis Investigative Site, Miami, Florida, United States
- Ionis Investigative Site, Miramar, Florida, United States
- Ionis Investigative Site, Flint, Michigan, United States
- Ionis Investigative Site, Munroe Falls, Ohio, United States
- Ionis Investigative Site, Little River, South Carolina, United States
- Ionis Investigative Site, Lampasas, Texas, United States
- Ionis Investigative Site, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Severe Hypertriglyceridemia
This study will evaluate the efficacy and safety of plozasiran in approximately 288 adult participants with severe hyper…
Los Angeles, United StatesEst. completion Mar 2029
Still Disease
The primary objective of the study is to evaluate the efficacy and safety of goflikicept (GFC) and olokizumab (OKZ) in p…
Izhevsk, RussiaEst. completion Dec 14, 2027
Phase 3
Recruiting
This is an open-label study to be conducted in adults with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (S…
Bakersfield, United StatesEst. completion Jul 2028